Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Neuroinform.

This article is part of the Research TopicAI and Natural Learning Systems: Bi-Directional InsightsView all 4 articles

Assessing the Eligibility of Brainomix e-ASPECTS for Acute Stroke Imaging

Provisionally accepted
Mateusz  DorochowiczMateusz Dorochowicz1*Arkadiusz  KacałaArkadiusz Kacała1,2Michał  PułaMichał Puła1Adrian  KorbeckiAdrian Korbecki1Aleksandra  KosikowskaAleksandra Kosikowska3Aleksandra  TołkaczAleksandra Tołkacz3Anna  ZimnyAnna Zimny1,2Maciej  GuzińskiMaciej Guziński1,2
  • 1Department of General, Interventional and Neuroradiology, Wroclaw University Hospital, 50-556 Wrocław, Poland, Wrocław, Poland
  • 2Department of Radiology, Wroclaw Medical University, Borowska str. 213, 50-556 Wroclaw, Poland, Wrocław, Poland
  • 3Faculty of Medicine, Wroclaw Medical University, 50-367 Wrocław, Poland, Wrocław, Poland

The final, formatted version of the article will be published soon.

ABSTRACT Background: Timely and accurate assessment of acute ischemic stroke is crucial for determining eligibility for mechanical thrombectomy. The Alberta Stroke Program Early CT Score (ASPECTS) is a widely used tool for evaluating early ischemic changes on non-contrast CT (NCCT), but its interpretation is subject to interobserver variability. Brainomix e-ASPECTS is an automated software designed to standardize and expedite this assessment. We aimed to evaluate the clinical utility and diagnostic performance of the Brainomix e-ASPECTS software in an unselected, real-world cohort of patients undergoing NCCT for suspected acute ischemic stroke. Methods: We retrospectively analyzed 1029 NCCT studies from 954 patients between March 2020 and December 2024. e-ASPECTS scores were compared to radiologist-assigned ASPECTS, which served as the reference standard. Diagnostic accuracy, sensitivity, specificity, and correlation between scoring methods were assessed. Results: There was a strong correlation between e-ASPECTS and radiologist ASPECTS (ρ = 0.953, p < 0.001). For detecting acute ischemia, sensitivity was 95.8 % (95% CI, 93.6-97.3%), specificity 96.9% (95% CI, 94.7-98.2%), and overall accuracy 96.3% (95% CI, 95.1–97.5%). The positive predictive value was 97.2% (95% CI, 95.3-98.4%), and the negative predictive value was 95.3% (95% CI, 92.8-96.9%). Score concordance was high, with exact matches in 92.3% of cases and a ≤1-point difference in 97.7%. Misclassification for thrombectomy eligibility (ASPECTS < 6) occurred in four cases (0.4%). The software achieved a processing success rate of 91.9%. Conclusion: E-ASPECTS demonstrates high diagnostic accuracy and strong agreement with expert radiological assessment, supporting its role as a valuable decision support tool in acute stroke imaging. However, its use should complement, not replace, expert interpretation, particularly in patients with low ASPECTS scores, where treatment decisions are most sensitive.

Keywords: e-ASPECTS, Acute ischemic stroke, Artificial Intelligence in Stroke Imaging, Mechanical Thrombectomy Eligibility, Clinical decision support systems (CDS System), Stroke Imaging Algorithms, Healthcare AI Validation

Received: 17 Jul 2025; Accepted: 20 Nov 2025.

Copyright: © 2025 Dorochowicz, Kacała, Puła, Korbecki, Kosikowska, Tołkacz, Zimny and Guziński. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mateusz Dorochowicz, m.dorochowicz@outlook.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.